Archives for November, 2009
Celexa: SSRI, Popular in Europe, Approved for Depression
Posted By Kelly On Monday, November 30th 2009 under: Celexa (Citalopram) Tags: Antidepressant, Depression, Drugs, Medications
Citalopram (Celexa, Forest Laboratories, Parke-Davis) has been approved by FDA for treatment of depression. A highly selective serotonin reuptake inhibitor, citalopram is the best-selling antidepressant in 13 countries, including eight in Europe. Citalopram has proven effective in treatment of depression in clinical trials involving 23,000 patients and has been used in some 8 million patients in 64 countries where the drug is already approved. Two, six-month, double-blind, placebo-controlled studies indicated ... Read More
Depression And The Social Environment
Posted By Kelly On Sunday, November 29th 2009 under: Book review Tags: Depression
Depression And The Social Environment: Research And Intervention With Neglected Populations
Editors: Philippe CappeUez; Robert J. Flyrm McGill
Queen's University Press, 3430 McTavish St, Montreal, QCH3A 1X9, 1993, 428 ppl
The title of this book clearly expresses the concepts within. It is well written and includes fairly complete literature reviews, along with some of the authors' personal work on research related to depression in specific populations. Most of the populations studied are often ... Read More
Risk Management with Suicidal Patients
Posted By Kelly On Saturday, November 28th 2009 under: Book review Tags: Depression, Drugs, Mental health, Suicide
Risk Management with Suicidal Patients
Bongar B, Berman AL, Mavis RW, Silverman MM, Harris EA, Pakman WL, editors
New York: The Guilford Press; 1998.197 pp with index
ISBN 1-57230-302-6 (cloth)
This book was written in response to the fact that most psychiatrists lose a patient to suicide sometime during their professional life. Suicide cases are a leading reason for malpractice action against mental health professionals. Dr. Bongar begins ... Read More
“Old” vs. “New” Medications
Posted By Kelly On Saturday, November 28th 2009 under: Question - Answer Tags: Drugs, Medications, Schizophrenia, Seroquel, Zyprexa
Question. My 18-year-old son was diagnosed schizophrenic two years ago. Currently hospitalized, he is receiving clozapine and Haldol as anti-psychotics and Paxil for depression. He was moved directly to clozapine from Risperdal and has gained over 60 lbs. in three months. I've heard that olanzapine acts much like clozapine, but with fewer side effects. Is it normal to move to "older" drugs before exhausting newer ones?
Answer. I appreciate how confusing ... Read More
How To Take Seroquel (Quetiapine Fumarate)
Posted By Kelly On Saturday, November 28th 2009 under: Seroquel (Quetiapine) Tags: Antidepressant, Drugs, Medications, Seroquel
Please keep the following information in mind when taking Seroquel®(Quetiapine Fumarate).
Making Seroquel tablets work for you
Seroquel is available as tablets you take by mouth. You should take Seroquel tablets every day or as your doctor has directed. To gain the most benefits from Seroquel tablets, take the exact number of tablets your doctor has prescribed for you each day at the appropriate times. Regardless of how good or how ... Read More
The Effect of Seroquel in Long-Term Treatment of Patients With Schizophrenia
Posted By Kelly On Saturday, November 28th 2009 under: Seroquel (Quetiapine) Tags: Antidepressant, Drugs, Schizophrenia, Seroquel, Treatment
Clinical data recently presented at a major US psychiatric conference suggest that Seroquel ® (Quetiapine Fumarate) Tablets continue to be safe, effective and well-tolerated in the long-term treatment of both positive and negative symptoms of schizophrenia in adults.
Positive and negative symptoms of schizophrenia
Major features of schizophrenia include positive symptoms such as delusions, and hallucinations, and negative symptoms such as apathy, depression, and social withdrawal. While ... Read More
Facts About Seroquel (Quetiapine Fumarate) Tablets
Posted By Kelly On Saturday, November 28th 2009 under: Seroquel (Quetiapine) Tags: Drugs, Seroquel
• In September 1997, Seroquel was cleared for marketing by the US Food and Drug Administration (FDA). Seroquel is an oral medication indicated for the management of the manifestations of psychotic disorders, including schizophrenia.
• Seroquel belongs to a new chemical class of atypical antipsychotics known as dibenzothiazepine derivatives.
• Three, short-term (six weeks or less) controlled trials of psychotic patients demonstrated that Seroquel is effective in treating both the positive and ... Read More
Tranquillizer and Antidepressant Drugs in Practice. Part 3
Posted By Kelly On Friday, November 27th 2009 under: Depression Tags: Antidepressants, Canada, Depression, Drugs
(Country: Canada)
Psychiatric Problems in Children
Tranquillizers have been used to a moderate degree in the treatment of similar psychiatric conditions in children, as in the anxiety reactions and the associated somatic symptoms. They are also of value in childhood schizophrenia. Promethazine has been a particularly helpful drug with very minimal side effects. Promazine and thioridazine have proved to have a similar function. Children who have such problems as speech defects, enuresis, ... Read More
Tranquillizer and Antidepressant Drugs in Practice. Part 2
Posted By Kelly On Friday, November 27th 2009 under: Depression Tags: Antidepressants, Canada, Depression, Drugs
(Country: Canada)
Miscellaneous Group
The drugs in the miscellaneous group which are most widely used are meprobamate and Librium.
Meprobamate is marketed under the trade names of Equanil, Miltown and Tranquiline. It has presented minimal toxic effects but has been misused by many people prone to drug addiction. The drug is essentially an effective medication for anxiety reactions but should be avoided, or at least used with considerable caution, in individuals with character ... Read More
Tranquillizer and Antidepressant Drugs in Practice. Part 1
Posted By Kelly On Friday, November 27th 2009 under: Depression Tags: Antidepressants, Canada, Depression, Drugs
(Country: Canada)
A healthy controversy continues to be manifested in the field of psychiatry concerning the use of drug therapy. This controversy is related to the following factors:
(a) The complexity of new drugs and the multiplicity of drugs offered from month to month to the physician.
(b) The difficulty in determining the effect of the drug as distinct from the psychological influence of placebo administration.
(c) The pressure on the ... Read More
